Previous studies of blast crisis chronic myeloid leukemia (CML) have reported that elevated expression of CD36 in LSCs is associated with increased FAO and protection from chemotherapy [14,23]. This evidence concerns the gene CD36 and chronic myelogenous leukemia, BCR-ABL1 positive.